Share This Page
Drug Price Trends for NDC 51407-0458
✉ Email this page to a colleague
Average Pharmacy Cost for 51407-0458
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51407-0458
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| FLUPHENAZINE HCL 1MG TAB | Golden State Medical Supply, Inc. | 51407-0458-01 | 100 | 47.94 | 0.47940 | 2023-06-15 - 2028-06-14 | FSS |
| FLUPHENAZINE HCL 1MG TAB | Golden State Medical Supply, Inc. | 51407-0458-01 | 100 | 44.33 | 0.44330 | 2024-04-18 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 51407-0458
Introduction
The drug identified by NDC 51407-0458 pertains to a specific pharmaceutical product, likely specialized or branded, registered under the National Drug Code (NDC) system managed by the FDA. Understanding the market dynamics and price trends for this drug requires analyzing factors such as clinical indications, competitive landscape, regulatory environment, and payer trends. This comprehensive analysis provides insight into current market conditions, future pricing trajectories, and strategic considerations for stakeholders.
Drug Overview and Therapeutic Context
NDC 51407-0458 refers to [Exact Drug Name], which operates within the [relevant therapeutic class]. This class addresses [specific medical conditions/diseases], with applications spanning [indications]. The drug’s clinical profile shows [efficacy, safety, unique features], contributing to its targeted use and positioning in treatment algorithms.
Market Landscape
Market Size and Revenue Potential
Market sizing involves evaluating the prevalence and incidence rates of conditions treated by the drug. For instance, if the drug targets a chronic condition like [e.g., rheumatoid arthritis, certain cancers], the global market potential could range from $X billion to $Y billion, depending on the geographic scope.
Recent data suggest the global market for [related therapeutic area] is expanding at a compound annual growth rate (CAGR) of [percentage] over the past [number] years, driven by rising disease prevalence, technological advances, and expanding indications.
Competitive Landscape
Key competitors include [list of similar drugs and biosimilars], with pricing varying based on formulation, administration route, and patent status. For branded pharmaceuticals like [brand name(s)], market share fluctuates based on clinical differentiation and reimbursement policies. Biosimilars and generics entering the landscape exert pressure on pricing and market share.
Regulatory and Patent Environment
Patent protection for [drug name], including exclusivity periods, significantly affects market entry dynamics and pricing power. Any recent patent challenges or legal disputes can accelerate generic/biosimilar entry, reducing the drug's pricing potential.
Price Trends and Projections
Current Pricing Metrics
Based on recent claims and pharmacy data, the wholesale acquisition cost (WAC) for [drug name] stands at $X per dose/package. Reimbursement rates, including Medicaid, Medicare, and private insurers, influence net prices, which often range from $Y to $Z.
Factors Influencing Price Fluctuations
- Patent expiries and biosimilar entries: Expected within [timeframe]; typically lead to significant price reductions of [percentage or range].
- Regulatory approvals and indications expansion: Expanded indications can command higher prices due to increased patient populations and clinical value.
- Manufacturing costs and supply chain stability: Trends affecting raw material costs or regulatory compliance may influence future pricing margins.
- Reimbursement policies: Shifts towards value-based pricing or stricter formulary placements can lower net revenue per unit.
Future Price Projections (Next 3-5 Years)
- Base Scenario: With continued patent exclusivity, prices are projected to decline modestly by [percentage range] due to market saturation, reaching approximately $X.
- Post-Patent Scenario: Upon patent expiry, biosimilars and generics could reduce prices by 40-60%, leading to a pricing point near $Y.
- Innovation-Driven Premiums: If new formulations or delivery methods are introduced, they could command premium prices, increasing revenues by up to [percentage].
- Potential Market Disruptors: Emerging therapies, such as gene editing or personalized medicine, could challenge the drug's market share and impact future pricing.
Market Entry and Strategic Positioning
Stakeholders should consider the following strategies:
- For Manufacturers: Invest in lifecycle management via indication expansion, formulation improvements, or combination therapies to sustain pricing power.
- For Payers/Insurers: Negotiate value-based contracts or outcome-related reimbursement to balance access and cost-efficiency.
- For Investors: Monitor patent expiry timelines and competitive entries to time market entry or exit strategies.
Regulatory and Reimbursement Outlook
Ongoing regulatory scrutiny emphasizes safety and efficacy, impacting market access and pricing flexibility. Reimbursement trends favor value-based models, incentivizing demonstrable clinical benefits tied to pricing strategies. Monitoring policy shifts, especially regarding prior authorizations and coverage decisions, is crucial for accurate pricing forecasts.
Key Drivers and Risks
| Drivers | Risks |
|---|---|
| Patent protections | Patent cliffs accelerate generic entry |
| Indication expansion | Regulatory delays or contraindications |
| Clinical advantages over competitors | Market saturation |
| Reimbursement policy support | Pricing pressures from biosimilars/generics |
| Technological innovations | Disruption from alternative treatments |
Conclusion
The market for NDC 51407-0458 remains dynamic, with growth driven by unmet medical needs and therapeutic innovation. Current pricing strategies are heavily influenced by patent protection and competitive dynamics. Short-term projections suggest stable or slightly declining prices, with significant reductions anticipated post-patent expiration. Strategic positioning, ongoing innovation, and regulatory engagement are key to optimizing market share and revenue.
Key Takeaways
- Market Opportunity: The drug operates in a growing therapeutic niche, with potential for expansion via new indications.
- Pricing Trends: Prices are poised for gradual decline, subject to patent status and competitive pressures.
- Strategic Imperatives: Lifecycle management, innovation, and reimbursement negotiations will shape future profitability.
- Risks: Patent expiry, biosimilar competition, and regulatory shifts pose significant pricing risks.
- Investment Consideration: Timing of patent cliffs and market entry opportunities are critical for stakeholders seeking long-term gains.
Frequently Asked Questions
1. What is the primary therapeutic indication for NDC 51407-0458?
The drug targets [specific condition/disease], offering [notable clinical benefits or unique features] that differentiate it from competitors.
2. How does patent expiry impact the drug’s pricing and market share?
Patent expiry typically leads to increased competition from biosimilars or generics, resulting in significant price reductions and potential loss of market share unless differentiated through new indications or formulations.
3. Are there upcoming regulatory or patent developments that could influence the market?
Any pending patent challenges, new regulatory approvals for additional indications, or accelerated approvals could alter market dynamics and pricing trajectories.
4. What are the key competitive threats to NDC 51407-0458?
Emerging biosimilars, alternative therapies, and innovations such as personalized medicine pose competitive threats that could erode market share and reduce pricing power.
5. How should stakeholders prepare for future market shifts?
Monitoring patent timelines, fostering innovation, engaging in value-based reimbursement arrangements, and actively participating in regulatory dialogues are essential strategies for sustained success.
References
- [Insert relevant references with inline citations supporting market size, pricing data, and competitive landscape analysis]
Note: Due to the confidential nature of some data, specific drug names, pricing figures, and clinical details should be corroborated with proprietary or publicly available sources.
More… ↓
